Keratoprosthesis prophylaxis: is it time for a paradigm shift?
JS Pelletier,1–3 SB Barone,1 JA Capriotii1,2 1Department of Ophthalmology, Veloce BioPharma LLC, Fort Lauderdale, FL, USA; 2Department of Ophthalmology, Plessen Ophthalmology Consultants, Christiansted, VI, USA; 3Department of Ophthalmology, Ocean Ophthalmology Group, Miami, FL, USA Abst...
Enregistré dans:
Auteurs principaux: | Pelletier JS, Barone SB, Capriotti JA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b051d6c841ca4371a752fdfcb6fbbc4f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Comparison of Povidone-Iodine and Gentamicin Soak as Scleral Buckle Infection Prophylaxis
par: Lin X, et autres
Publié: (2021) -
Boston type 1 keratoprosthesis from patient selection through postoperative management: a review for the keratoprosthetic surgeon
par: Williamson SL, et autres
Publié: (2016) -
Long-term outcomes of the aphakic snap-on Boston type I keratoprosthesis at the Bascom Palmer Eye Institute
par: Gibbons A, et autres
Publié: (2018) -
Keyhole Anterior Lamellar Keratoplasty for Boston Keratoprosthesis Corneal Melt
par: John T, et autres
Publié: (2021) -
Boston Type 1 Keratoprosthesis: Updated Perspectives
par: Nonpassopon M, et autres
Publié: (2020)